HS-20093 Antibody is an antibody-drug conjugate (ADC) targeting B7-H3, demonstrating antitumor activity. It is applicable for research involving small cell lung cancer, relapsed or refractory osteosarcoma, and advanced solid tumors.
Target:
Antibody-Drug Conjugates (ADCs)|||Immunology/Inflammation related
* VAT and and shipping costs not included. Errors and price changes excepted